Pfizer pharmaceuticals settles case on suicide allegedly caused by use of its drug Chantix

Following several attempts to postpone the start of the first Chantix product liability trial, which was set to begin on Monday, Pfizer has reportedly reached an agreement to settle the case.  The lawsuit had been brought by the family of a man who committed suicide while taking the stop-smoking drug. This is only one of an estimated 2,500 Chantix cases, with all federal lawsuits consolidated as part of a multidistrict litigation, which has been centralized before U.S. District Judge Inge Johnson in the Northern District of Alabama.  For more information and links go to AboutLawsuits.com.